Trevena Announces $2M Non-Dilutive Financing Tranche and Reduction in Outstanding Liabilities in Connection with Existing ex-US Royalty Financing Jul 8, 2024 9:15 am EDT
Trevena Announces Preclinical TRV045 Data Providing Insight Into Novel Mechanism of Analgesic Effect in Chronic Neuropathic Pain Model and Demonstrating Statistically Significant Anti-Seizure Activity in Epilepsy Models Jun 20, 2024 7:00 am EDT
Trevena Announces the Closing of $4 Million Concurrent Private Placement and Warrant Exercise Dec 28, 2023 2:00 pm EST
Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise Dec 27, 2023 9:10 am EST